Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9387569 | 0.81 | TDP1 (0.32) | TDP1ALDH1A1MAPT | |
| SCHEMBL7171035 | 0.78 | ALOX5 (0.33) | TDP1ALDH1A1MAPT | |
| SCHEMBL7553639 | 0.76 | POLB (0.31) | — | |
| SCHEMBL7174885 | 0.75 | KDM4E (0.33) | ALDH1A1MAPT | |
| SCHEMBL2306809 | 0.73 | — | — | |
| SCHEMBL7160266 | 0.71 | KDM4E (0.31) | — | |
| SCHEMBL29249163 | 0.66 | — | — | |
| SCHEMBL713734 | 0.64 | GRM4 (0.30) | — | |
| Bicarbonate SCHEMBL9195144 | 0.63 | TDP1 (0.69) | TDP1ALDH1A1MAPT | |
| SCHEMBL11544898 | 0.63 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6506913-B2 | Wood preservatives | SANKYO COMPANY, LIMITED (JP) | 2003-01-14 | — | — | US | disclosed |
| US-20020091154-A1 | Dimethylfurancarboxyanilide derivatives | SANKYO COMPANY LIMITED (JP) | 2002-07-11 | — | — | US | disclosed |
| US-6380247-B2 | A WOOD PRESERVATIVE; POTENTIATION WHEN MIXED WITH AT LEAST ONE OF 3-BROMO-2,3-DIIODO-2-PROPENYL-ETHYLCARBAMATE, 3-IODO-2-PROPYNYLBUTYL-CARBAMATE AND 4-CHLOROPHENYL-3-IODOPROPARGYLFORMAL; MICROBIOCIDES | SANKYO COMPANY, LIMITED (JP) | 2002-04-30 | — | — | US | disclosed |
| EP-0755927-B1 | DIMETHYLFURANCARBOXANILIDE DERIVATIVE | SANKYO CO (JP) | 2001-07-18 | — | — | EP | disclosed |
| US-20010000184-A1 | Dimethylfurancarboxyanilide derivatives | SANKYO COMPANY, LIMITED | 2001-04-05 | — | — | US | disclosed |
| US-5977168-A | 2,5-DIMETHYLFURAN-3-CARBOXYANILIDE DERIVATIVES | SANKYO COMPANY, LIMITED (JP) | 1999-11-02 | — | — | US | disclosed |
| EP-0755927-A1 | DIMETHYLFURANCARBOXANILIDE DERIVATIVE | SANKYO COMPANY LIMITED (JP) | 1997-01-29 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020091154-A1 | Dimethylfurancarboxyanilide derivatives | C9, CBR1, CBR3 | TDP1 1094/4885ALDH1A1 116/4885MAPT 3855/4885 |
| US-20010000184-A1 | Dimethylfurancarboxyanilide derivatives | C9, CBR1, CBR3 | TDP1 1094/4885ALDH1A1 116/4885MAPT 3855/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.